Form Bio Co. Ltd. (377220) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Form Bio Co. Ltd. (377220) has a cash flow conversion efficiency ratio of -0.070x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.57 Billion ≈ $-1.74 Million USD) by net assets (₩36.61 Billion ≈ $24.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 377220 net asset quality score to measure how much of total assets are equity-financed.
Form Bio Co. Ltd. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Form Bio Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 377220 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Form Bio Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Form Bio Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SEL Manufacturing Company Limited
NSE:SELMC
|
-0.055x |
|
Fanhua Inc
F:4CIA
|
0.021x |
|
AMD Industries Limited
NSE:AMDIND
|
0.104x |
|
Universal Security Instruments Inc
NYSE MKT:UUU
|
-1.142x |
|
RONSHINE CH.HLD.HD-00001
F:1R7
|
N/A |
|
Teera-Mongkol Industry Public Company Limited
BK:TMI
|
0.096x |
|
Acceleware Ltd
V:AXE
|
0.030x |
|
Aakash Exploration Services Limited
NSE:AAKASH
|
0.010x |
Annual Cash Flow Conversion Efficiency for Form Bio Co. Ltd. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Form Bio Co. Ltd. from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see 377220 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩49.10 Billion ≈ $33.28 Million |
₩-14.70 Billion ≈ $-9.96 Million |
-0.299x | -7.96% |
| 2023-12-31 | ₩75.17 Billion ≈ $50.94 Million |
₩-20.85 Billion ≈ $-14.13 Million |
-0.277x | -1105.44% |
| 2022-12-31 | ₩87.96 Billion ≈ $59.61 Million |
₩-2.02 Billion ≈ $-1.37 Million |
-0.023x | -65.33% |
| 2021-12-31 | ₩84.43 Billion ≈ $57.22 Million |
₩-1.17 Billion ≈ $-796.13K |
-0.014x | -102.11% |
| 2020-12-31 | ₩23.64 Billion ≈ $16.02 Million |
₩15.61 Billion ≈ $10.58 Million |
0.660x | +218.72% |
| 2019-12-31 | ₩-10.21 Billion ≈ $-6.92 Million |
₩5.68 Billion ≈ $3.85 Million |
-0.556x | -- |
About Form Bio Co. Ltd.
From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.